RxDoctor Payments Data

Jeffrey Rocco, MD

Orthopaedic Surgery · Washington Terrace, UTNPI 1306818190

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 15.3%. Reporting peaked in 2024 at $9,645 and has fallen 67.9% since, to $3,098 in 2025.

$30,488in general payments, 2019–2025

Across 409 payments — averaging $74.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microport Orthopedics Inc$5K
  • Stryker$4K
  • Medacta USA, Inc.$4K
  • Encore Medical, LP$4K
  • Smith+Nephew$3K
  • Radius Health, Inc.$3K
  • plus $7K from 40 others
$13,800in research payments, 2019–2025

Across 4 payments — averaging $3450.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Anika Therapeutics, Inc.$9K
  • Pacira Therapeutics, Inc.$5K

What the payments were for

  • Speaking & faculty fees$1,3204%
  • Travel & lodging$16,19853%
  • Food & beverage$11,72538%
  • Education$1,2454%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,488 in reported general payments places this provider in the 80th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$148,345
Medicare patients
250
Services billed
3,134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam79$373
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$360
Cephalexin12$130
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$126
Gabapentin14$86

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Washington Terrace

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →